Cargando…
Germline Met Mutations in Mice Reveal Mutation- and Background-Associated Differences in Tumor Profiles
BACKGROUND: The receptor tyrosine kinase Met is involved in the progression and metastasis of numerous human cancers. Although overexpression and autocrine activation of the Met signaling pathway are commonly found in human cancers, mutational activation of Met has been observed in small cell and no...
Autores principales: | Graveel, Carrie R., DeGroot, Jack D., Sigler, Robert E., Vande Woude, George F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963642/ https://www.ncbi.nlm.nih.gov/pubmed/21049054 http://dx.doi.org/10.1371/journal.pone.0013586 |
Ejemplares similares
-
Germline mutation rates and the long-term phenotypic effects of mutation accumulation in wild-type laboratory mice and mutator mice
por: Uchimura, Arikuni, et al.
Publicado: (2015) -
Somatic Tumor Profile Analysis in a Patient with Germline PMS2 Mutation and Synchronous Ovarian and Uterine Carcinomas
por: Huelsman, Karen M., et al.
Publicado: (2021) -
Revealing tumor heterogeneity of breast cancer by utilizing the linkage between somatic and germline mutations
por: Zou, Meng, et al.
Publicado: (2018) -
Investigation of founder effects for the Thr377Met Myocilin mutation in glaucoma families from differing ethnic backgrounds
por: Hewitt, Alex W., et al.
Publicado: (2007) -
Germline mutations in BAP1 predispose to melanocytic tumors
por: Wiesner, Thomas, et al.
Publicado: (2011)